구조 |
화학 이름 |
CAS |
MF |
![AZD-9291](/CAS/20150311/GIF/1421373-65-0.gif) |
AZD-9291 |
1421373-65-0 |
C28H33N7O2 |
![팔보시클립](/CAS/GIF/571190-30-2.gif) |
팔보시클립 |
571190-30-2 |
C24H29N7O2 |
![Tivozanib](/CAS2/GIF/475108-18-0.gif) |
Tivozanib |
475108-18-0 |
C22H19ClN4O5 |
![Lenvatinib](/CAS2/GIF/417716-92-8.gif) |
Lenvatinib |
417716-92-8 |
C21H19ClN4O4 |
![PELITINIB](/CAS/GIF/257933-82-7.gif) |
PELITINIB |
257933-82-7 |
C24H23ClFN5O2 |
![카보잔티닙](/CAS/GIF/849217-68-1.gif) |
카보잔티닙 |
849217-68-1 |
C28H24FN3O5 |
![Masitinib](/CAS/GIF/790299-79-5.gif) |
Masitinib |
790299-79-5 |
C28H30N6OS |
![Dacomitinib (PF299804)](/CAS/GIF/1110813-31-4.gif) |
Dacomitinib (PF299804) |
1110813-31-4 |
C24H25ClFN5O2 |
![Pazopanib Hydrochloride](/CAS/GIF/635702-64-6.gif) |
Pazopanib Hydrochloride |
635702-64-6 |
C21H24ClN7O2S |
![Linifanib (ABT-869)](/CAS/GIF/796967-16-3.gif) |
Linifanib (ABT-869) |
796967-16-3 |
C21H18FN5O |
![CO-1686](/CAS/20150408/GIF/1374640-70-6.gif) |
CO-1686 |
1374640-70-6 |
C27H28F3N7O3 |
![SU 11274](/CAS/GIF/658084-23-2.gif) |
SU 11274 |
658084-23-2 |
C28H30ClN5O4S |
![Amuvatinib](/CAS2/GIF/850879-09-3.gif) |
Amuvatinib |
850879-09-3 |
C23H21N5O3S |
![포레티닙(GSK1363089)](/CAS/GIF/849217-64-7.gif) |
포레티닙(GSK1363089) |
849217-64-7 |
C34H34F2N4O6 |
![WZ4002](/CAS/GIF/1213269-23-8.gif) |
WZ4002 |
1213269-23-8 |
C25H27ClN6O3 |
![J&J Ex-61](/CAS/GIF/943540-75-8.gif) |
J&J Ex-61 |
943540-75-8 |
C19H13F2N7 |
![NVP-TAE684](/CAS/GIF/761439-42-3.gif) |
NVP-TAE684 |
761439-42-3 |
C30H40ClN7O3S |
![알렉티닙](/CAS/GIF/1256580-46-7.gif) |
알렉티닙 |
1256580-46-7 |
C30H34N4O2 |
![AEE788](/CAS/GIF/497839-62-0.gif) |
AEE788 |
497839-62-0 |
C27H32N6 |
![Crenolanib](/CAS/20150408/GIF/670220-88-9.gif) |
Crenolanib |
670220-88-9 |
C26H29N5O2 |
![AVL-292](/CAS/20150408/GIF/1202757-89-8.gif) |
AVL-292 |
1202757-89-8 |
C22H22FN5O3 |
![AC480 (BMS-599626)](/CAS/GIF/714971-09-2.gif) |
AC480 (BMS-599626) |
714971-09-2 |
C27H27FN8O3 |
![AMG-706](/CAS/20180713/GIF/857876-30-3.gif) |
AMG-706 |
857876-30-3 |
C22H29N5O9P2 |
![LY 2874455](/CAS/20150408/GIF/1254473-64-7.gif) |
LY 2874455 |
1254473-64-7 |
C21H19Cl2N5O2 |
![AP26113](/CAS/20150408/GIF/1197958-12-5.gif) |
AP26113 |
1197958-12-5 |
C26H34ClN6O2P |
![GW441756](/CAS/GIF/504433-23-2.gif) |
GW441756 |
504433-23-2 |
C17H13N3O |
![Vatalanib Dihydrochloride](/CAS/GIF/212141-51-0.gif) |
Vatalanib Dihydrochloride |
212141-51-0 |
C20H17Cl3N4 |
![Momelotinib](/CAS2/GIF/1056634-68-4.gif) |
Momelotinib |
1056634-68-4 |
C23H22N6O2 |
![AZD8931](/CAS/20150408/GIF/848942-61-0.gif) |
AZD8931 |
848942-61-0 |
C23H25ClFN5O3 |
![Cabozantinib Malate](/CAS/GIF/1140909-48-3.gif) |
Cabozantinib Malate |
1140909-48-3 |
C32H30FN3O10 |
![Afatinib dimaleate](/CAS/20181012/GIF/850140-73-7.gif) |
Afatinib dimaleate |
850140-73-7 |
C28H29ClFN5O7 |
![Orantinib (SU6668)](/CAS/GIF/252916-29-3.gif) |
Orantinib (SU6668) |
252916-29-3 |
C18H18N2O3 |
![코비메티닙](/CAS/GIF/934660-93-2.gif) |
코비메티닙 |
934660-93-2 |
C21H21F3IN3O2 |
![SGX-523](/CAS/GIF/1022150-57-7.gif) |
SGX-523 |
1022150-57-7 |
C18H13N7S |
![1-Cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/CAS2/GIF/1092788-83-4.gif) |
1-Cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
1092788-83-4 |
C17H17N7 |
![AG 1478 HYDROCHLORIDE](/CAS/GIF/153436-53-4.gif) |
AG 1478 HYDROCHLORIDE |
153436-53-4 |
C16H14ClN3O2 |
![PD04217903](/CAS/GIF/956905-27-4.gif) |
PD04217903 |
956905-27-4 |
C19H16N8O |
![REVERSINE](/CAS/GIF/656820-32-5.gif) |
REVERSINE |
656820-32-5 |
C21H27N7O |
![AMG 458](/CAS/20150408/GIF/913376-83-7.gif) |
AMG 458 |
913376-83-7 |
C30H29N5O5 |
![Linsitinib](/CAS/GIF/867160-71-2.gif) |
Linsitinib |
867160-71-2 |
C26H23N5O |
![GNF 5837](/CAS/20150408/GIF/1033769-28-6.gif) |
GNF 5837 |
1033769-28-6 |
C28H21F4N5O2 |
![Ki8751](/CAS/GIF/228559-41-9.gif) |
Ki8751 |
228559-41-9 |
C24H18F3N3O4 |
![IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea](/CAS/GIF/196868-63-0.gif) |
IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea |
196868-63-0 |
C18H16ClN3O2 |
![(2R)-1-[[5-[(Z)-[5-[[(2,6-DICHLOROPHENYL)METHYL]SULFONYL]-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE]METHYL]-2,4-DIMETHYL-1H-PYRROL-3-YL]CARBONYL]-2-(1-PYRROLIDINYLMETHYL)PYRROLIDINE](/CAS/GIF/477575-56-7.gif) |
(2R)-1-[[5-[(Z)-[5-[[(2,6-DICHLOROPHENYL)METHYL]SULFONYL]-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE]METHYL]-2,4-DIMETHYL-1H-PYRROL-3-YL]CARBONYL]-2-(1-PYRROLIDINYLMETHYL)PYRROLIDINE |
477575-56-7 |
C32H34Cl2N4O4S |
![N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide](/CAS2/GIF/875337-44-3.gif) |
N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide |
875337-44-3 |
C26H20FN5O2S2 |
![NVP-BHG712](/CAS/GIF/940310-85-0.gif) |
NVP-BHG712 |
940310-85-0 |
C26H20F3N7O |
![Tepotinib](/CAS/GIF/1100598-32-0.gif) |
Tepotinib |
1100598-32-0 |
C29H28N6O2 |
![Apatinib](/CAS/20150408/GIF/811803-05-1.gif) |
Apatinib |
811803-05-1 |
C24H23N5O |
![TAK-285](/CAS/20150408/GIF/871026-44-7.gif) |
TAK-285 |
871026-44-7 |
C26H25ClF3N5O3 |
![TYRPHOSTIN AG 1296](/CAS/GIF/146535-11-7.gif) |
TYRPHOSTIN AG 1296 |
146535-11-7 |
C16H14N2O2 |
![GDC-0941 Bimesylate](/CAS/GIF/957054-33-0.gif) |
GDC-0941 Bimesylate |
957054-33-0 |
C24H30N7O6S3 |
![세리티닙](/CAS/20150408/GIF/1032900-25-6.gif) |
세리티닙 |
1032900-25-6 |
C28H36ClN5O3S |
![TYRPHOSTIN AG 879](/CAS/GIF/148741-30-4.gif) |
TYRPHOSTIN AG 879 |
148741-30-4 |
C18H24N2OS |
![Capmatinib](/CAS/GIF/1029712-80-8.gif) |
Capmatinib |
1029712-80-8 |
C23H17FN6O |
![BMS-754807](/CAS/GIF/1001350-96-4.gif) |
BMS-754807 |
1001350-96-4 |
C23H24FN9O |
![Tie2키나제억제제](/CAS2/GIF/948557-43-5.gif) |
Tie2키나제억제제 |
948557-43-5 |
C26H21N3O2S |
![BMS-794833](/CAS/20150408/GIF/1174046-72-0.gif) |
BMS-794833 |
1174046-72-0 |
C23H15ClF2N4O3 |
![Lorlatinib](/CAS/20150408/GIF/1454846-35-5.gif) |
Lorlatinib |
1454846-35-5 |
C21H19FN6O2 |
![LRRK2-IN-1](/CAS/GIF/1234480-84-2.gif) |
LRRK2-IN-1 |
1234480-84-2 |
C31H38N8O3 |
![ARRY-334543](/CAS/GIF/845272-21-1.gif) |
ARRY-334543 |
845272-21-1 |
C22H19ClN6O2S |
![골바티닙(E7050)](/CAS/GIF/928037-13-2.gif) |
골바티닙(E7050) |
928037-13-2 |
C33H37F2N7O4 |
![2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-1H-IMIDAZOLE](/CAS/GIF/189224-48-4.gif) |
2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-1H-IMIDAZOLE |
189224-48-4 |
C13H14N2O |
![Mk-2461 .](/CAS/GIF/917879-39-1.gif) |
Mk-2461 . |
917879-39-1 |
C24H25N5O5S |
![WZ8040](/CAS/GIF/1214265-57-2.gif) |
WZ8040 |
1214265-57-2 |
C24H25ClN6OS |
![Insulin-like Growth Factor-1 Receptor Inhibitor](/CAS/20181012/GIF/468740-43-4.gif) |
Insulin-like Growth Factor-1 Receptor Inhibitor |
468740-43-4 |
C25H26ClN5O3 |
![5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/CAS/GIF/475488-23-4.gif) |
5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
475488-23-4 |
C28H31N5O |
![OSI-420](/CAS/20210111/GIF/183320-51-6.gif) |
OSI-420 |
183320-51-6 |
C21H22ClN3O4 |
![SR 1078](/CAS/20150408/GIF/1246525-60-9.gif) |
SR 1078 |
1246525-60-9 |
C17H10F9NO2 |
![AST-1306](/CAS/20150408/GIF/1050500-29-2.gif) |
AST-1306 |
1050500-29-2 |
C31H26ClFN4O5S |
![AVP-AEW541](/CAS/GIF/475489-16-8.gif) |
AVP-AEW541 |
475489-16-8 |
C27H29N5O |
![ALK/IGF1R inhibitor](/CAS/20150408/GIF/1356962-20-3.gif) |
ALK/IGF1R inhibitor |
1356962-20-3 |
C24H25ClN6O |
![ZM 306416](/CAS/GIF/690206-97-4.gif) |
ZM 306416 |
690206-97-4 |
C16H13ClFN3O2 |
![3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon](/CAS/GIF/194413-58-6.gif) |
3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon |
194413-58-6 |
C15H14N2O |
![AMG-208](/CAS/GIF/1002304-34-8.gif) |
AMG-208 |
1002304-34-8 |
C22H17N5O2 |
![KRN 633](/CAS/20150408/GIF/286370-15-8.gif) |
KRN 633 |
286370-15-8 |
C20H21ClN4O4 |
![R428](/CAS/20150408/GIF/1037624-75-1.gif) |
R428 |
1037624-75-1 |
C30H34N8 |
![렌바티닙메실레이트](/CAS/20180713/GIF/857890-39-2.gif) |
렌바티닙메실레이트 |
857890-39-2 |
C22H23ClN4O7S |
![CP-724714](/CAS/GIF/537705-08-1.gif) |
CP-724714 |
537705-08-1 |
C27H27N5O3 |
![OSI-930](/CAS/GIF/728033-96-3.gif) |
OSI-930 |
728033-96-3 |
C22H16F3N3O2S |
![NVP-BVU 972](/CAS/GIF/1185763-69-2.gif) |
NVP-BVU 972 |
1185763-69-2 |
C20H16N6 |
![UNC2881](/CAS/20150408/GIF/1493764-08-1.gif) |
UNC2881 |
1493764-08-1 |
C25H33N7O2 |
![TYRPHOSTIN AG 1024](/CAS/GIF/65678-07-1.gif) |
TYRPHOSTIN AG 1024 |
65678-07-1 |
C14H13BrN2O |
![PD153035 HCl](/CAS/GIF/183322-45-4.gif) |
PD153035 HCl |
183322-45-4 |
C16H14BrN3O2.HCl |
![ARRY-380](/CAS/GIF/937265-83-3.gif) |
ARRY-380 |
937265-83-3 |
C29H27N7O4S |
![NVP-BSK805](/CAS/20150408/GIF/1092499-93-8.gif) |
NVP-BSK805 |
1092499-93-8 |
C27H28F2N6O |
![N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine](/CAS/GIF/1097917-15-1.gif) |
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine |
1097917-15-1 |
C29H40N8O3S |
![ANA12](/CAS/20180713/GIF/219766-25-3.gif) |
ANA12 |
219766-25-3 |
C22H21N3O3S |
![5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine](/CAS2/GIF/870483-87-7.gif) |
5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine |
870483-87-7 |
C20H22N4O3 |
![1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine](/CAS2/GIF/343787-29-1.gif) |
1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine |
343787-29-1 |
C24H27N5O2 |
![GSK1838705A](/CAS/20180713/GIF/1116235-97-2.gif) |
GSK1838705A |
1116235-97-2 |
C27H29FN8O3 |
![3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione](/CAS/GIF/905854-02-6.gif) |
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione |
905854-02-6 |
C23H19N3O2 |
![WZ3146](/CAS/GIF/1214265-56-1.gif) |
WZ3146 |
1214265-56-1 |
C24H25ClN6O2 |
![Icotinib](/CAS/GIF/610798-31-7.gif) |
Icotinib |
610798-31-7 |
C22H21N3O4 |
![UNC2250](/CAS/20150408/GIF/1493694-70-4.gif) |
UNC2250 |
1493694-70-4 |
C24H36N6O2 |
![PD168393](/StructureFile/ChemBookStructure5/GIF/CB8316129.gif) |
PD168393 |
194423-15-9 |
C17H13BrN4O |
![2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]-](/CAS/GIF/194423-06-8.gif) |
2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]- |
194423-06-8 |
C18H13BrN4O |
![SAR 131675](/CAS/20180906/GIF/1433953-83-3.gif) |
SAR 131675 |
1433953-83-3 |
C18H22N4O4 |
![ZM 323881 hydrochloride](/CAS/GIF/193000-39-4.gif) |
ZM 323881 hydrochloride |
193000-39-4 |
C22H19ClFN3O2 |
![CNX-2006](/CAS/20150408/GIF/1375465-09-0.gif) |
CNX-2006 |
1375465-09-0 |
C26H27F4N7O2 |
![SKLB1002](/CAS/20150408/GIF/1225451-84-2.gif) |
SKLB1002 |
1225451-84-2 |
C13H12N4O2S2 |